Remdesivir approved for use in treatment of severe COVID-19 patients
The injectable medicine has been allowed for administration as part of a maximum five-day regimen
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CDSCO
Gilead seeks marketing authorisation from CDSCO for remdesivir
The medicine has been issued EUA by the US FDA to treat hospitalised coronavirus patients
CDSCO to procure data on stock position of medical oxygen for 18 months
It has issued a list of 26 medical oxygen manufacturers from across the country and asked for several details to be furnished by…
CDSCO asks PPE manufacturers to register voluntarily on its med device portal
The government has notified eight laboratories for testing and accrediting materials of PPE kits
High-level panel to recommend reforms in India’s drug regulations
The panel, chaired by Rajesh Bhushan, the OSD to the Union Health Minister, comprises top drug and vaccine entrepreneurs as well…
US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India
Officials of the Union Health Ministry, along with DCGI held a discussion with the representatives of Gilead Sciences to prepare a…
NovaLead Pharma to conduct clinical trials for repurposed drug for COVID-19
The drug, code-named NLP21, is in human use for several years for its original approved usage without any side effects of concern
CDSCO observes lower supply of 15 drugs used for COVID-19 treatment
Asks drug manufacturers associations to ensure adequate production, supply and availability of these 15 drugs
Govt nod for manufacture of COVID-19 vaccine before clinical trials end will expedite access:…
Though certain rules have been deferred by the Government in the public interest to meet the emergent situation that has arisen…
CDSCO issues recommendations to lift export restrictions on paracetamol APIs
The letter states that six major manufacturers may be allowed to export up to 50 per cent of their monthly operating capacity in a…